Response to Comments: Botulinum Toxin Types A and B

This record (A55383) is Noridian's response to provider recommendations regarding botulinum toxin types A and B for the comment period ending 2016-08-08. The provided excerpt contains no explicit coverage indications, limitations, documentation requirements, or frequency limits; review of the full policy or attached coverage determination is required to extract actionable criteria.

"This document is a 'Response to Provider Recommendations' and the provided excerpt does not state explicit coverage exclusions or denials for botulinum toxin types A or B."

Sign up to see full coverage criteria, indications, and limitations.